News

First Therapeutically Equivalent Velcade Generics Approved

May 2, 2022

Read More »

Brand Medications with Generic Alternatives Anticipated to be Approved in May

May 1, 2022

Read More »

Rinvoq Now Indicated for Ankylosing Spondylitis

April 29, 2022

Read More »

Ultomiris Granted New Myasthenia Gravis Indication

April 28, 2022

Read More »

Vivjoa Approved to Treat Chronic Yeast Infections

April 28, 2022

Read More »

First-in-Class Treatment Approved for Hypertrophic Cardiomyopathy

April 28, 2022

Read More »

New Caplyta Dosage Strengths Approved

April 25, 2022

Read More »

FDA Approves New Benzoyl Peroxide Product for Rosacea

April 25, 2022

Read More »

Veklury Approved to Treat COVID-19 in Younger Patient Population

April 25, 2022

Read More »

Benefit Advisors & Employees - Want to know more?

Members: Please call the number on the back of your ID card or e-mail member.services@benecardpbf.com Clients: Contact your Client Relations Manager

Full Name(Required)

Email(Required)

Comment(Required)

Company Name(Required)

CAPTCHA